Trials and tribulations in charged particle radiotherapy
- PMID: 19581014
- DOI: 10.1016/j.radonc.2009.06.012
Trials and tribulations in charged particle radiotherapy
Abstract
A number of aspects of radiotherapy using protons and ions such as carbon and neon are discussed, focusing less on the oft-enumerated advantages or potential advantages of these particles as on those aspects which are, or may be, problematic. First, for protons and so-called heavy ions separately, the potential advantages and disadvantages of the particles, on physical and radiobiological grounds, are reviewed and some outstanding problems, both technical and scientific, are enumerated. Then, mention is made of the danger that financial pressures can lead to suboptimal medical care of patients. Finally, the issue of clinical trials, and especially randomized clinical trials, is addressed. On the one hand, very few randomized trials have been reported. On the other hand, there is a widespread desire to see trials of charged particle therapy undertaken. The ethical considerations are briefly reviewed and it is concluded that they pose strong limitations on the types of trials which can be undertaken. Nevertheless, some clinical trials would certainly be appropriate and desirable and a number are suggested, under the categories of retrospective non-randomized clinical trials, prospective non-randomized clinical trials, and prospective-randomized clinical trials.
Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Medical physics aspects of particle therapy.Radiat Prot Dosimetry. 2009 Nov;137(1-2):156-66. doi: 10.1093/rpd/ncp192. Epub 2009 Oct 14. Radiat Prot Dosimetry. 2009. PMID: 19828718
-
The clinical experience with particle therapy in adults.Cancer J. 2009 Jul-Aug;15(4):306-11. doi: 10.1097/PPO.0b013e3181b01922. Cancer J. 2009. PMID: 19672147 Review.
-
Basics of particle therapy II biologic and dosimetric aspects of clinical hadron therapy.Am J Clin Oncol. 2010 Dec;33(6):646-9. doi: 10.1097/COC.0b013e3181cdf0fe. Am J Clin Oncol. 2010. PMID: 20395789 Review.
-
Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.J Radiol Prot. 2009 Jun;29(2A):A143-57. doi: 10.1088/0952-4746/29/2A/S10. Epub 2009 May 19. J Radiol Prot. 2009. PMID: 19454805 Review.
-
Particle radiation therapy using proton and heavier ion beams.J Clin Oncol. 2007 Mar 10;25(8):953-64. doi: 10.1200/JCO.2006.09.7816. J Clin Oncol. 2007. PMID: 17350944 Review.
Cited by
-
A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton study.Radiother Oncol. 2014 Oct;113(1):77-83. doi: 10.1016/j.radonc.2014.08.033. Epub 2014 Oct 16. Radiother Oncol. 2014. PMID: 25443861 Free PMC article. Clinical Trial.
-
Patient positioning in the proton radiotherapy era.J Exp Clin Cancer Res. 2010 May 13;29(1):47. doi: 10.1186/1756-9966-29-47. J Exp Clin Cancer Res. 2010. PMID: 20465816 Free PMC article. Review.
-
The physical basis and future of radiation therapy.Br J Radiol. 2011 Jun;84(1002):485-98. doi: 10.1259/bjr/86221320. Br J Radiol. 2011. PMID: 21606068 Free PMC article. Review.
-
An approximate analytical solution of the Bethe equation for charged particles in the radiotherapeutic energy range.Sci Rep. 2017 Aug 29;7(1):9781. doi: 10.1038/s41598-017-10554-0. Sci Rep. 2017. PMID: 28852130 Free PMC article.
-
Proton therapy with a fixed beamline for skull-base chordomas and chondrosarcomas: outcomes and toxicity.Radiat Oncol. 2021 Dec 20;16(1):238. doi: 10.1186/s13014-021-01961-9. Radiat Oncol. 2021. PMID: 34930352 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources